chartexchange

XGN
Exagen Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:55 PM EST
3.91USD+3.989%(+0.15)473,168
After-hoursNov 18, 2026 4:00:30 PM EST
3.90USD-0.256%(-0.01)
Loading…
Loading…
Healthcare
Diagnostics & Research
HQ
Vista, CA, USA
Previous Close
$3.76
Beta
2.73
52-Week High
$9.22 2026-10-14
52-Week Low
$2.59 2026-03-30
SMA 50
$7.56
SMA 200
$5.12
Avg. Vol 10D
1.31M
Avg. Vol 30D
667,517
Avg. Vol 90D
447,296
Relative Vol
0.71
14.13M
0.2800%
5,600
XGN Profile

exagen diagnostics, inc. is a patient focused, discovery driven, clia-certified, cap-accredited laboratory with a growing menu of proprietary, internally developed tests focusing in the area of rheumatology and autoimmune diseases. committed to personalized medicine, our avise tests are specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management. for more information on our company, please visit www.exagen.com. for more information on avise testing services, please visit www.avisetest.com.

XGN Performance
PeriodPriceDateChangeBeta
1W5.042026-11-11-22.34%-1.011
1M7.432026-10-19-47.38%3.251
3M6.592026-08-18-40.67%2.992
6M3.492026-05-18+12.03%3.293
1Y8.212025-11-18-52.38%2.728
2Y3.002024-11-18+30.33%—
5Y12.252021-11-18-68.08%1.260
XGN Stock Summary

Exagen Inc. Common Stock (NASDAQ:XGN) stock price today is $3.91, and today's volume is 473,168. XGN is up 3.989% today. The 30 day average volume is 667,517. XGN market cap is $99.76M with 25.51M shares outstanding.